OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/22/2025
Back to search
Official data from USPTO
AMVELOUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
08/23/2025
Trademark type
Word
Nice classes
5
Filing date
12/11/2023
Registration date
11/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2024
Last transaction
08/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
65
Owner location
DK
Examiner
RIRIE, VERNA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Novo Nordisk A/S
Representatives
Novo Nordisk A/S | Novo Nordisk A/S
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of cardiovascular diseases.
Publications
History of USPTO decisions and trademark events.
13 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/06/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/06/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2024
PUBO
PUBLISHED FOR OPPOSITION
08/20/2024
NPUB
NOTICE OF PUBLICATION
07/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2024
DOCK
ASSIGNED TO EXAMINER
07/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/07/2024
Continuous trademark protection
Get notified about every new filing that threatens AMVELOUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.